Muutke küpsiste eelistusi

E-raamat: Key Trials in Cardiothoracic Surgery [Taylor & Francis e-raamat]

Edited by , Edited by , Edited by
  • Formaat: 193 pages, 1 Tables, black and white
  • Ilmumisaeg: 10-Oct-2023
  • Kirjastus: CRC Press
  • ISBN-13: 9781003424994
Teised raamatud teemal:
  • Taylor & Francis e-raamat
  • Hind: 203,11 €*
  • * hind, mis tagab piiramatu üheaegsete kasutajate arvuga ligipääsu piiramatuks ajaks
  • Tavahind: 290,16 €
  • Säästad 30%
Key Trials in Cardiothoracic SurgerySuurem pilt
  • Formaat: 193 pages, 1 Tables, black and white
  • Ilmumisaeg: 10-Oct-2023
  • Kirjastus: CRC Press
  • ISBN-13: 9781003424994
Teised raamatud teemal:
Taylor & Francis e-raamatudRohkem infot Taylor & Francis e-raamatute kohta
Raamatu kodulehekülg: https://www.taylorfrancis.com/books/9781003424994
"A concise summary of the most important clinical trials in cardiac and thoracic surgery. The focus is on how evidence-based decision making has helped to shape modern practice and guidelines. The key trials are described and an overview of their impact provided"--

A concise summary of the most important clinical trials in cardiac and thoracic surgery. The focus is on how evidence-based decision making has helped to shape modern practice and guidelines. The key trials are described and an overview of their impact provided.

Much research has been undertaken to study the efficacy of different drugs, techniques, and treatment strategies within cardiothoracic surgery. As a result, many randomised controlled trials have been published which discuss a wide variety of topics and with the intention of improving current practice and patient care. This volume presents a selection of the key trials and assesses their impact. Compact and easy to read, the distillation of core information will enable the reader to understand the importance of the key papers that have influenced best practice across operating theatres, clinics, multi-disciplinary meetings, and inpatient management.

Including full summaries of more than 30 trials and reflecting the clinical scenarios encountered in everyday practice by cardiothoracic surgeons, this concise volume is written for both trainee and more experienced members of the surgical team.



A concise summary of the most important clinical trials in cardiac and thoracic surgery. The focus is on how evidence-based decision making has helped to shape modern practice and guidelines. The key trials are described and an overview of their impact provided.

I - Thoracic
Chapters:

Chapter 1: Lung cancer screening.

    • NLST

    • UK trial

    • Nelson trial

Chapter 2: Surgical approach.

    • VATS vs Open

    • VATS vs RATS

Chapter 3: Volume of surgical resection.

Chapter 4: Lung Cancer Surveillance After Definitive Curative treatment

Chapter 5: Management of primary spontaneous pneumothorax

Chapter 6: Thymectomy in myasthenia gravis

Chapter 7: Surgical treatment of Mesothelioma

Chapter 8: Surgical treatment of ribs fracture

Chapter 9: Treatment of advanced emphysema

    • Lung Volume Reduction Surgery vs medical treatment

    • Endobronchial valve for severe emphysema vs medical treatment

    • Lung volume reduction surgery vs endobronchial valve

Chapter 10: SABR vs wedge resection

Chapter 11: Pulmonary metastasectomy in colorectal cancer

Chapter 12: Adjuvant EGFR-TKI treatment.

Chapter 13: Durvalumab in advanced lung cancer

Chapter 14: Management of prolonged air leak

    • Management of chest drain and air leak

    • Management of Prolonged Air Leak with Autologous Blood Patch

II- Cardiac chapters:

Chapter 15: Off-pump vs On-pump CABG

Chapter 16: TAVI vs standard approach

    • TAVI vs surgery for low-risk patients

    • TAVI vs surgery for intermediate risk patients

    • TAVI vs surgery for high-risk patients

Chapter 17: Surgical Treatment of Ischaemic MR.

Chapter 18: Radial artery graft vs Venous graft and RITA.

Chapter 19: Surgical treatment of AF.

Chapter 20: Surgical treatment of asymptomatic severe AS.

Chapter 21: Blood transfusion post cardiac surgery.

Chapter 22: Multivessel revascularization in patients with diabetes.

Chapter 23: Surgery in Infective Endocarditis.

Chapter 24: LIMA alone vs LIMA+RIMA.

Chapter 25: PCI vs CABG:

    • In left main coronary disease

    • For left main coronary disease

Ghaith Isam Qsous, MRCS

Cardiothoracic Speciality Doctor Royal Infirmary Edinburgh (UK)

Malcolm Will, FRCS (CTh)

Thoracic Surgery Consultant - Royal Infirmary Edinburgh (UK)

Vipin Zamvar, FRCS (CTh)

Cardiothoracic Surgery Consultant - Royal Infirmary Edinburgh (UK)
Püsilink: https://www.kriso.ee/db/9781003424994_pe.html
Märksõnad: